8 drug(s) with this reaction
3,776 total reports
Hypotension has been reported as an adverse reaction across 8 drug(s) manufactured by Amgen Inc in the FDA Adverse Event Reporting System (FAERS) database. A combined total of 3,776 adverse event reports mention hypotension in connection with Amgen Inc products.
This page provides a breakdown of which Amgen Inc drugs are most commonly associated with hypotension, along with report counts and links to detailed safety analyses for each medication. Understanding which drugs from a single manufacturer share a common adverse reaction can help patients and healthcare providers identify potential class-wide safety patterns.
The following Amgen Inc drugs have hypotension listed in their FDA adverse event reports, sorted by report count:
In addition to hypotension, the following adverse reactions have been reported across Amgen Inc's drug portfolio:
8 drug(s) manufactured by Amgen Inc have hypotension listed in their FDA adverse event reports: FILGRASTIM, DARBEPOETIN ALFA, PEGFILGRASTIM, CINACALCET HYDROCHLORIDE, EPOETIN ALFA, and others.
There are a combined 3,776 reports of hypotension across 8 Amgen Inc drug(s) in the FDA adverse event database.